Not every company has the resources to add dedicated alliance managers, but nearly all biopharmaceutical companies have alliances and partnerships. What are the essential alliance management practices that must be employed in all alliances to manage risk and realize value? How can people who have another job – such as program management or business development – provide the support needed for the collaboration, not just the technical work?
Christine and Kal will explore the strategies and tactics required when you wear more than one hat to:
- Be an effective part-time alliance manager
- Get organizational commitment to creating collaboration value
- Manage internal and alliance decision making
Christine A. Carberry, CSAP
Senior Vice President, Quality, Technical Operations, Program & Alliance Management
Christine Carberry is a biopharmaceutical executive with extensive experience across all phases of global drug development. Since joining FORUM in 2012, Christine’s leadership role has expanded to include the Quality function, where she holds responsibility for the company’s GMP, GCP, GLP, audit, and quality systems. Christine also directs FORUM’s Technical Operations covering process development, analytical development, formulation development, and supply chain. In her Program & Alliance Management role, she focuses on the cross-functional integration of drug development and strategic alliances, including FORUM’s collaboration in Japan.
Prior to FORUM, Christine was at Biogen Idec for over 25 years. She held positions of increasing responsibility as the company advanced from a biotechnology pioneer to an internationally recognized Fortune 500 company. As VP Program & Alliance Management, she led global co-development/co-commercialization alliances, strategic planning, R&D operations and program management. Christine began her healthcare career at Biogen in technical operations positions including process development, manufacturing, technical training, and supply chain. She also led the start-up of Biogen’s first European manufacturing facility.
Christine is a Certified Strategic Alliance Professional (CSAP). She holds an M.S. in innovation and technology management from Boston University, Certificates in Management and Biotechnology Strategy from Harvard University, and a B.S. in biochemistry from the University of New Hampshire.
Kal Lapan, PhD
Director, Alliance and Program Management
Kal Lapan has been the Director of Alliance and Program Management at Epizyme since 2011. At Epizyme, she was responsible for establishing internal alliance management capabilities, in addition to instituting mechanisms to enable project and portfolio management. Kal manages relationships with Epizyme’s major partners (Celgene, Eisai, GSK, Abbott and Roche) interacting cross-functionally with R&D, preclinical and clinical project teams. After receiving a BA from Williams College and PhD from the University of Rochester, she began her post-graduate career as a scientist at Cubist Pharmaceuticals and Novartis. Prior to joining Epizyme, Kal enhanced her interest and skills in alliance management through positions in operations (at Boston Biochem , an R&D subsidiary) and project management ( at the Dana Farber Cancer Institute).